arrow
E

Eileen M. O'Reilly

Memorial Sloan Kettering Cancer Center
H指数:100
被引数:4.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Outcomes of Chemoimmunotherapy in Metastatic Pancreatic Neuroendocrine Carcinoma: A Single-Center Clinicopathologic Study

转移性胰腺神经内分泌癌的化疗免疫治疗效果:一项单中心临床病理研究

2026-10-280
OAAI
Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic cancer: the randomized phase 2 AMPLIFY-7P trial

淋巴结靶向、mKRAS特异性的两亲性疫苗在胰腺癌中的研究:AMPLIFY-7P随机II期试验

2026-10-230
OAAI
Letter to the Editor: further reply to Kahl et al. regarding ‘NALIRIFOX versus nab-paclitaxel and gemcitabine in older patients with treatment-naive metastatic pancreatic cancer: a subgroup analysis of the pivotal NAPOLI 3 trial’

致编辑的信:关于“NALIRIFOX与 nab-paclitaxel 和 gemcitabine 在老年初治转移性胰腺癌患者中的比较:关键性 NAPOLI 3 试验的亚组分析”的进一步回复给 Kahl 等人

2026-10-090
OAAI
Evaluation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Localized Pancreatic Cancer: Trans-Atlantic Pancreatic Surgery Consortium Study

评估无进展生存期作为局部胰腺癌总生存期替代终点的价值:大西洋两岸胰腺外科联盟研究

2026-09-260
OAAI
Response to Letter to the Editor: 'NALIRIFOX versus nab-paclitaxel and gemcitabine in older patients with treatment-naive metastatic pancreatic cancer: a subgroup analysis of the pivotal NAPOLI 3 trial'

对编辑来信的回应:'NALIRIFOX与nab-紫杉醇和吉西他滨在治疗初治转移性胰腺癌老年患者中的比较:关键性NAPOLI 3试验的亚组分析'

2026-07-010
OAAI
Hepatic artery infusion pump chemotherapy for unresectable intrahepatic cholangiocarcinoma: Pooled individual patient-level analysis of four clinical trials

肝动脉灌注泵化疗治疗不可切除的肝内胆管癌:四项临床试验的个体患者水平荟萃分析

2026-06-220
PRE
Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial

Pembrolizumab和olaparib治疗同源重组缺陷型转移性胰腺癌: 2期POLAR试验

2026-03-250
OAAI
NALIRIFOX versus nab-paclitaxel and gemcitabine in older patients with treatment-naive metastatic pancreatic cancer: a subgroup analysis of the pivotal NAPOLI 3 trial

NALIRIFOX与nab-紫杉醇和吉西他滨在治疗初治转移性胰腺癌老年患者中的比较:NAPOLI 3关键试验的亚组分析

2026-02-120
OAAI
Genomic evolution of pancreatic cancer at single-cell resolution

单细胞分辨率的胰腺癌基因组进化

2026-01-220
OAAI
NRG1 fusion-positive solid tumors: clinical detection, genomic landscape, and real-world data in pancreatic cancer

NRG1融合阳性实体瘤:临床检测、基因组景观及胰腺癌的真实世界数据

2025-12-130
OA
Radiomic signatures to estimate survival in patients with advanced hepatocellular carcinoma treated with sorafenib: Cancer and Leukemia Group B 80802 (Alliance)

基于索拉非尼治疗的晚期肝细胞癌患者生存预测的放射组学特征:癌症与白血病小组B 80802(联盟)研究

2025-12-020
OAAI
ASO Visual Abstract: Outcomes of First-versus Second-Line Hepatic Artery Infusion Chemotherapy in Unresectable Intrahepatic Cholangiocarcinoma

ASO视觉摘要:不可切除性肝内胆管癌中,一线与二线肝动脉灌注化疗的疗效比较

2025-11-170
PRE
Safety and Feasibility of Intra-Arterial Treatment of Pancreatic Cancer Using an Emulsion of Ethiodized Oil plus Bumetanide in an Oncopig Model

使用乙碘油与布美他尼乳剂进行经动脉治疗胰腺癌的安全性与可行性:一项在肿瘤猪模型中的研究

2025-11-050
PRE
Sex differences in chemotherapy completion, toxicities, and survival in colon cancer: an analysis of 2201 patients from CALGB/SWOG 80702 (Alliance)

结直肠癌化疗完成情况、毒性和生存的性别差异:一项基于CALGB/SWOG 80702 (Alliance) 2201例患者的分析

2025-11-010
PRE